Pregnancy outcome with maternal HNF1B gene mutations and 17q12 deletions.
Adam MortonLing LiCaroline WilsonPublished in: Obstetric medicine (2022)
There is an increasing body of literature regarding monogenic diabetes, particularly the more common forms of glucokinase and HNF1-alpha mutations (MODY2 and MODY3). There is relatively little published literature regarding rarer mutations. HNF1-beta mutations and 17q12 deletions may be associated with a broad range of organ dysfunction, renal disease and diabetes in particular resulting in high-risk pregnancies. This manuscript describes pregnancy outcomes in a woman with an HNF1-beta mutation and 2 women with an HNF1B /17q12 deletion and reviews the previously published literature. It highlights the significant rate of adverse maternal and fetal outcomes, and the maternal features suggestive of the diagnosis which should be considered in preconception counselling.
Keyphrases
- pregnancy outcomes
- pregnant women
- nuclear factor
- systematic review
- type diabetes
- cardiovascular disease
- glycemic control
- toll like receptor
- meta analyses
- birth weight
- oxidative stress
- metabolic syndrome
- adipose tissue
- emergency department
- preterm birth
- smoking cessation
- case report
- skeletal muscle
- insulin resistance
- hiv testing
- antiretroviral therapy
- adverse drug